P. W. B. de la Porte

Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.

A. Voors, D. V. van Veldhuisen, W. V. van Gilst, 2008, European heart journal.

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

H. Hillege, D. V. van Veldhuisen, D. Lok, 2010, Clinical Research in Cardiology.

Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer–Alkmaar heart failure study

A. Hoes, N. Zuithoff, J. Cornel, 2006, Heart.

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

H. Hillege, D. V. van Veldhuisen, D. Lok, 2010, Clinical Research in Cardiology.